Literature DB >> 16985924

The Use of Nomograms for Selecting BPH Candidates for Dutasteride Therapy.

Kevin M Slawin, Michael W Kattan.   

Abstract

Recent studies have discussed the benefits of medical therapy for benign prostatic hyperplasia (BPH), but have not provided physicians with the necessary tools needed to translate the information into individualized, evidence-based recommendations for clinically important questions. Nomograms can help physicians individualize their treatment decisions and predict a likely outcome by assessing the key risk factors for BPH progression.

Entities:  

Year:  2004        PMID： 16985924      PMCID： PMC1472915     

Source DB:  PubMed          Journal:  Rev Urol        ISSN： 1523-6161


  9 in total

1.  Natural history of prostatism: risk factors for acute urinary retention.

Authors:  S J Jacobsen; D J Jacobson; C J Girman; R O Roberts; T Rhodes; H A Guess; M M Lieber
Journal:  J Urol       Date:  1997-08       Impact factor: 7.450

2.  Comparison of Cox regression with other methods for determining prediction models and nomograms.

Authors:  Michael W Kattan
Journal:  J Urol       Date:  2003-12       Impact factor: 7.450

3.  Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group.

Authors:  C G Roehrborn; J D McConnell; M Lieber; S Kaplan; J Geller; G H Malek; R Castellanos; S Coffield; B Saltzman; M Resnick; T J Cook; J Waldstreicher
Journal:  Urology       Date:  1999-03       Impact factor: 2.649

4.  The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group.

Authors:  J D McConnell; R Bruskewitz; P Walsh; G Andriole; M Lieber; H L Holtgrewe; P Albertsen; C G Roehrborn; J C Nickel; D Z Wang; A M Taylor; J Waldstreicher
Journal:  N Engl J Med       Date:  1998-02-26       Impact factor: 91.245

5.  Nomograms as predictive models.

Authors:  James A Eastham; Michael W Kattan; Peter T Scardino
Journal:  Semin Urol Oncol       Date:  2002-05

6.  Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride versus placebo. PLESS Study Group.

Authors:  C G Roehrborn; P Boyle; D Bergner; T Gray; M Gittelman; T Shown; A Melman; R B Bracken; R deVere White; A Taylor; D Wang; J Waldstreicher
Journal:  Urology       Date:  1999-10       Impact factor: 2.649

7.  The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia.

Authors:  John D McConnell; Claus G Roehrborn; Oliver M Bautista; Gerald L Andriole; Christopher M Dixon; John W Kusek; Herbert Lepor; Kevin T McVary; Leroy M Nyberg; Harry S Clarke; E David Crawford; Ananias Diokno; John P Foley; Harris E Foster; Stephen C Jacobs; Steven A Kaplan; Karl J Kreder; Michael M Lieber; M Scott Lucia; Gary J Miller; Mani Menon; Douglas F Milam; Joe W Ramsdell; Noah S Schenkman; Kevin M Slawin; Joseph A Smith
Journal:  N Engl J Med       Date:  2003-12-18       Impact factor: 91.245

8.  Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia.

Authors:  Claus G Roehrborn; Peter Boyle; J Curtis Nickel; Klaus Hoefner; Gerald Andriole
Journal:  Urology       Date:  2002-09       Impact factor: 2.649

9.  Natural history of prostatism: longitudinal changes in voiding symptoms in community dwelling men.

Authors:  S J Jacobsen; C J Girman; H A Guess; T Rhodes; J E Oesterling; M M Lieber
Journal:  J Urol       Date:  1996-02       Impact factor: 7.450
  9 in total
  5 in total

1.  BPH nomogram using IPSS, prostate volume, peak flow rate, PSA and median lobe protrusion for predicting the need for intervention: development and internal validation.

Authors:  Arvind P Ganpule; Rohan S Batra; Nitiraj B Shete; Abhishek G Singh; Ravindra B Sabnis; Mahesh R Desai
Journal:  Am J Clin Exp Urol       Date:  2021-06-15

2.  Baseline characteristics predict risk of progression and response to combined medical therapy for benign prostatic hyperplasia (BPH).

Authors:  Michael A Kozminski; John T Wei; Jason Nelson; David M Kent
Journal:  BJU Int       Date:  2014-08-13       Impact factor: 5.588

3.  Role of Acoustic Radiation Force Impulse (ARFI) Elastography in Determination of Severity of Benign Prostate Hyperplasia.

Authors:  Bircan Alan; Mazhar Utangaç; Cemil Göya; Mansur Dağgülli
Journal:  Med Sci Monit       Date:  2016-11-23

4.  A Novel Nomogram Based on Initial Features to Predict BPH Progression.

Authors:  Lorenzo G Luciani; Daniele Mattevi; Daniele Ravanelli; Umberto Anceschi; Guido Giusti; Tommaso Cai; Umberto Rozzanigo
Journal:  Int J Environ Res Public Health       Date:  2022-08-08       Impact factor: 4.614

5.  Relationship between Lower Urinary Tract Symptoms and Prostatic Urethral Stiffness Using Strain Elastography: Initial Experiences.

Authors:  Jong Kyou Kwon; Do Kyung Kim; Joo Yong Lee; Jong Won Kim; Kang Su Cho
Journal:  J Clin Med       Date:  2019-11-09       Impact factor: 4.241
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.